Crestline Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-18,660	Closed	-$1.45M	–	241
2017 Q4	$1.45M	Sell	18,660 -44,369	-70%	-$3.44M	0.15%	65
2017 Q3	$3.86M	Buy	63,029 +18,371	+41%	+$1.13M	0.54%	23
2017 Q2	$2.05M	Buy	+44,658	New	+$2.05M	0.28%	39